|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
178,600,000 |
Market
Cap: |
243.79(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8901 - $1.85 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 7.4 |
Insider 3/6 Months : 8 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
Total People Bought |
0 |
1 |
4 |
8 |
Total Buy Transactions |
0 |
1 |
6 |
12 |
Total Shares Sold |
0 |
96,686 |
455,706 |
505,706 |
Total Sell Value |
$0 |
$136,327 |
$650,097 |
$765,097 |
Total People Sold |
0 |
1 |
6 |
6 |
Total Sell Transactions |
0 |
1 |
21 |
22 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sterling Rick L. |
Chief Financial Officer |
|
2021-01-05 |
4 |
AS |
$10.56 |
$64,404 |
D/D |
(6,096) |
340,020 |
|
-28% |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,940 |
288,870 |
|
- |
|
Sabzevari Helen |
President and CEO |
|
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,667 |
424,299 |
|
- |
|
Lehr Donald P. |
Chief Legal Officer |
|
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,940 |
284,329 |
|
- |
|
Sterling Rick L. |
Chief Financial Officer |
|
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,940 |
346,116 |
|
- |
|
Sabzevari Helen |
President and CEO |
|
2021-01-04 |
4 |
AS |
$10.16 |
$53,635 |
D/D |
(5,279) |
406,632 |
|
-42% |
|
Lehr Donald P. |
Chief Legal Officer |
|
2021-01-04 |
4 |
AS |
$10.16 |
$53,553 |
D/D |
(5,271) |
265,389 |
|
-42% |
|
Sterling Rick L. |
Chief Financial Officer |
|
2021-01-04 |
4 |
AS |
$10.16 |
$35,428 |
D/D |
(3,487) |
327,176 |
|
-42% |
|
Kirk Randal J |
Director |
|
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,444 |
18,317,026 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2021-01-04 |
4 |
AS |
$10.16 |
$50,302 |
D/D |
(4,951) |
269,930 |
|
-42% |
|
Sabzevari Helen |
President and CEO |
|
2021-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,766 |
411,911 |
|
- |
|
Lehr Donald P. |
Chief Legal Officer |
|
2021-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,766 |
270,660 |
|
- |
|
Sterling Rick L. |
Chief Financial Officer |
|
2021-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,766 |
330,663 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2021-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,766 |
274,881 |
|
- |
|
Kirk Randal J |
Director |
|
2020-12-17 |
4 |
A |
$0.00 |
$0 |
I/I |
11,306,281 |
1,260,538 |
|
- |
|
Kirk Randal J |
Director |
|
2020-12-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(13,583,646) |
0 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,268 |
265,115 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-12-16 |
4 |
AS |
$7.20 |
$67,550 |
D/D |
(9,382) |
258,847 |
|
6% |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-12-16 |
4 |
AS |
$7.20 |
$67,795 |
D/D |
(9,416) |
320,897 |
|
6% |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-12-16 |
4 |
AS |
$7.20 |
$87,768 |
D/D |
(12,190) |
260,894 |
|
6% |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
268,229 |
|
- |
|
Sterling Rick L. |
Chief Financial Officer |
|
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
330,313 |
|
- |
|
Lehr Donald P. |
Chief Legal Officer |
|
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
273,084 |
|
- |
|
Ares Trading S.a. |
10% Owner |
|
2020-10-07 |
4 |
B |
$3.70 |
$24,999,997 |
D/D |
6,758,400 |
27,398,519 |
2.45 |
78% |
|
Kirk Randal J |
Executive Chairman |
|
2020-09-24 |
4 |
A |
$3.50 |
$74,998 |
I/I |
21,428 |
13,517,050 |
|
- |
|
617 Records found
|
|
Page 11 of 25 |
|
|